Infection, Infectious Agents and Vascular Disease

Author(s): Nicola Ielapi, Francesco Caprino, Biagio Malizia, Antonio Sisinni, Lwanga Ssempijja, Michele Andreucci, Noemi Licastro, Raffaele Serra*

Journal Name: Reviews on Recent Clinical Trials

Volume 16 , Issue 3 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Infectious agents may be involved in the pathogenesis of vascular disease and related complications. The aim of this review is to analyze the most relevant information on the common infections related to vascular disease, discussing the main pathophysiological mechanisms.

Methods: In the current review, the most important evidence on the issue of infections and vascular disease is searched on Medline, Scopus, and ScienceDirect database.

Results: Among infectious agents, herpesviruses, parvovirus B19, hepatitis viruses, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, treponema pallidum, mycobacterium tuberculosis, pseudomonas aeruginosa, staphylococcus aureus, and candida albicans seem to particularly related to vascular disease.

Conclusion: Infectious agents may affect vessel’s homeostasis and functionality, both on the arterial and venous side, by means of several pathophysiological mechanisms such as dysregulation in vasomotor function, thromboembolic complications, initiation and progression of atherosclerosis, alteration of perivascular adipose tissue, recruiting inflammatory cells and molecules.

Keywords: Infection, vascular disease, infectious agents, artery, vein, inflammation.

[1]
Budzyński J, Wiśniewska J, Ciecierski M, Kędzia A. Association between bacterial infection and peripheral vascular disease: A review. Int J Angiol 2016; 25(1): 3-13.
[PMID: 26900306]
[2]
Serra R, Grande R, Butrico L, et al. Chronic wound infections: The role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther 2015; 13(5): 605-13.
[http://dx.doi.org/10.1586/14787210.2015.1023291] [PMID: 25746414]
[3]
Serra R, Grande R, Buffone G, et al. Extracellular matrix assessment of infected chronic venous leg ulcers: Role of metalloproteinases and inflammatory cytokines. Int Wound J 2016; 13(1): 53-8.
[http://dx.doi.org/10.1111/iwj.12225] [PMID: 24618232]
[4]
Serra R, Ielapi N, Barbetta A, Andreucci M, de Franciscis S. Novel biomarkers for cardiovascular risk. Biomarkers Med 2018; 12(9): 1015-24.
[http://dx.doi.org/10.2217/bmm-2018-0056] [PMID: 30126290]
[5]
Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol 2006; 24(2)(Suppl. 41): S71-81.
[PMID: 16859600]
[6]
Lv YL, Han FF, Gong LL, et al. Human cytomegalovirus infection and vascular disease risk: A meta-analysis. Virus Res 2017; 227: 124-34.
[http://dx.doi.org/10.1016/j.virusres.2016.09.010] [PMID: 27664838]
[7]
Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350(9075): 430-6.
[http://dx.doi.org/10.1016/S0140-6736(97)03079-1] [PMID: 9259669]
[8]
Achiron R, Gindes L, Kivilevitch Z, et al. Prenatal diagnosis of congenital agenesis of the fetal portal venous system. Ultrasound Obstet Gynecol 2009; 34(6): 643-52.
[http://dx.doi.org/10.1002/uog.7460] [PMID: 19953566]
[9]
Scherrer MAR, Rocha VB, Garcia LC. Behçet’s disease: Review with emphasis on dermatological aspects. An Bras Dermatol 2017; 92(4): 452-64.
[http://dx.doi.org/10.1590/abd1806-4841.20177359] [PMID: 28954091]
[10]
Hauer L, Pikija S, Schulte EC, Sztriha LK, Nardone R, Sellner J. Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: A systematic review. J Neuroinflammation 2019; 16(1): 19.
[http://dx.doi.org/10.1186/s12974-019-1409-4] [PMID: 30696448]
[11]
Leite J, Ribeiro A, Gonçalves D, Sargento-Freitas J, Trindade L, Duque V. Cerebral venous thrombosis as rare presentation of herpes simplex virus encephalitis. Case Rep Infect Dis 2019; 2019: 7835420.
[http://dx.doi.org/10.1155/2019/7835420] [PMID: 30800483]
[12]
Lal A, Dhamne MC, Hui AC, Ahmad A. Herpes simplex virus (HSV) encephalitis in a young man: An unusual course. BMJ Case Rep 2018; 2018: bcr2017222499.
[http://dx.doi.org/10.1136/bcr-2017-222499] [PMID: 29478004]
[13]
Mackay MT, Steinlin M. Recent developments and new frontiers in childhood arterial ischemic stroke. Int J Stroke 2019; 14(1): 32-43.
[http://dx.doi.org/10.1177/1747493018790064] [PMID: 30079825]
[14]
Marchalik R, Reserva J, Plummer MA, Braniecki M. Pemphigus vegetans with coexistent herpes simplex infection and deep venous thrombosis of the lower extremities. BMJ Case Rep 2015; 2015: bcr2015210143.
[http://dx.doi.org/10.1136/bcr-2015-210143] [PMID: 26178000]
[15]
Clark AK, Dhossche J, Korcheva VB, et al. Herpes zoster presenting as unilateral vasculitis. Dermatol Online J 2018; 24(11)
[http://dx.doi.org/13030/qt5dd717sw]
[16]
Lin TY, Yang FC, Lin CL, Kao CH, Lo HY, Yang TY. Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study. Medicine (Baltimore) 2016; 95(35): e4480.
[http://dx.doi.org/10.1097/MD.0000000000004480] [PMID: 27583856]
[17]
Nagel MA, Gilden D. Developments in varicella zoster virus vasculopathy. Curr Neurol Neurosci Rep 2016; 16(2): 12.
[http://dx.doi.org/10.1007/s11910-015-0614-5] [PMID: 26750127]
[18]
Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: Clinical, CSF, imaging, and virologic features. Neurology 2008; 70(11): 853-60.
[http://dx.doi.org/10.1212/01.wnl.0000304747.38502.e8] [PMID: 18332343]
[19]
Finkel TH, Török TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994; 343(8908): 1255-8.
[http://dx.doi.org/10.1016/S0140-6736(94)92152-0] [PMID: 7910276]
[20]
Tijssen P, Ed. Handbook of parvoviruses Boca Raton, Florida: CRC Press. 1990; Vol. II.
[21]
Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262(5130): 114-7.
[http://dx.doi.org/10.1126/science.8211117] [PMID: 8211117]
[22]
Hook EW III, Peeling RW. Syphilis control-a continuing challenge. N Engl J Med 2004; 351(2): 122-4.
[http://dx.doi.org/10.1056/NEJMp048126] [PMID: 15247352]
[23]
French P, Gomberg M, Janier M, Schmidt B, van Voorst Vader P, Young H. IUST. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS 2009; 20(5): 300-9.
[http://dx.doi.org/10.1258/ijsa.2008.008510] [PMID: 19386965]
[24]
Conde-Sendín MA, Amela-Peris R, Aladro-Benito Y, Maroto AA. Current clinical spectrum of neurosyphilis in immunocompetent patients. Eur Neurol 2004; 52(1): 29-35.
[http://dx.doi.org/10.1159/000079391] [PMID: 15237250]
[25]
Singh AE, Romanowski B. Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12(2): 187-209.
[http://dx.doi.org/10.1128/CMR.12.2.187] [PMID: 10194456]
[26]
Jessop SJ. Cutaneous leucocytoclastic vasculitis: A clinical and aetiological study. Br J Rheumatol 1995; 34(10): 942-5.
[http://dx.doi.org/10.1093/rheumatology/34.10.942] [PMID: 7582700]
[27]
Thomas DD, Navab M, Haake DA, Fogelman AM, Miller JN, Lovett MA. Treponema pallidum invades intercellular junctions of endothelial cell monolayers. Proc Natl Acad Sci USA 1988; 85(10): 3608-12.
[http://dx.doi.org/10.1073/pnas.85.10.3608] [PMID: 3285346]
[28]
Heggtveit HA. Syphilitic aortitis. A clinicopathologic autopsy study of 100 cases, 1950 to 1960. Circulation 1964; 29: 346-55.
[http://dx.doi.org/10.1161/01.CIR.29.3.346] [PMID: 14128825]
[29]
Roberts WC, Lensing FD, Kourlis H Jr, et al. Full blown cardiovascular syphilis with aneurysm of the innominate artery. Am J Cardiol 2009; 104: 1595e1600.
[http://dx.doi.org/10.1016/j.amjcard.2009.06.070]
[30]
Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res 1967; 20: 409e421.
[http://dx.doi.org/10.1161/01.RES.20.4.409]
[31]
Marconato R, Inzaghi A, Cantoni GM, Zappa M, Longo T. Syphilitic aneurysm of the abdominal aorta: report of two cases. Eur J Vasc Surg 1988; 2(3): 199-203.
[http://dx.doi.org/10.1016/S0950-821X(88)80077-X] [PMID: 3410070]
[32]
Waller BF, Reis RL, McIntosh CL, et al. Marfan cardiovascular disease without the Marfan syndrome. Chest 1980; 77: 533e540.
[http://dx.doi.org/10.1378/chest.77.4.533]
[33]
Roberts WC, Honig HS. The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J 1982; 104: 115e135.
[http://dx.doi.org/10.1016/0002-8703(82)90650-0]
[34]
Anderson C, Rizzo R, Cohn L. Ascending aortic aneurysms.Cardiac Surgery in the Adult Cohn LH Edmunds New York McGraw-Hill. 2003; pp. pp 1123-1148.
[35]
Roeke T, Hovsibian S, Schlejen PM, Dinant S, Koster T, Waasdorp EJ. A mycotic aneurysm of the abdominal aorta caused by Mycobacterium bovis after intravesical instillation with bacillus Calmette-Guérin. J Vasc Surg Cases Innov Tech 2018; 4(2): 122-5.
[http://dx.doi.org/10.1016/j.jvscit.2018.01.008] [PMID: 29942898]
[36]
Vudatha V, Ranson M, Blair L, Ahmed AA. Rapid detection of bacille Calmette-Guérin-associated mycotic aortic aneurysm using novel cell-free DNA assay. J Vasc Surg Cases Innov Tech 2019; 5(2): 143-8.
[http://dx.doi.org/10.1016/j.jvscit.2018.11.006] [PMID: 31193416]
[37]
Delaval L, Goulenok T, Achouh P, et al. New insights on tuberculous aortitis. J Vasc Surg 2017; 66(1): 209-15.
[http://dx.doi.org/10.1016/j.jvs.2016.11.045] [PMID: 28254396]
[38]
Rajpal , Singh UB, Mohapatra S, et al. Association of Mycobacterium tuberculosis in the causation of Eales' disease: An institutional experience. Indian J Med Microbiol 2015; 33: 43-5.
[39]
Thayil SM, Albini TA, Nazari H, et al. Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One 2011; 6(12): e28383.
[http://dx.doi.org/10.1371/journal.pone.0028383] [PMID: 22162767]
[40]
Meziane M, Amraoui N, Taoufik H, Mernissi FZ. Cutaneous leukocytoclastic vasculitis revealing multifocal tuberculosis. Int J Mycobacteriol 2013; 2(4): 230-2.
[http://dx.doi.org/10.1016/j.ijmyco.2013.07.004] [PMID: 26786128]
[41]
Chen S, Chen J, Chen L, Zhang Q, Luo X, Zhang W. Mycobacterium tuberculosis infection is associated with the development of erythema nodosum and nodular vasculitis. PLoS One 2013; 8(5): e62653.
[http://dx.doi.org/10.1371/journal.pone.0062653] [PMID: 23650522]
[42]
Donnachie E, Fedotova EP, Hwang SA. Trehalose 6,6-Dimycolate from Mycobacterium tuberculosis Induces Hypercoagulation. Am J Pathol 2016; 186(5): 1221-33.
[http://dx.doi.org/10.1016/j.ajpath.2015.12.019] [PMID: 26968340]
[43]
Rota S, Rota S. Mycobacterium tuberculosis complex in atherosclerosis. Acta Med Okayama 2005; 59(6): 247-51.
[PMID: 16418767]
[44]
Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis: Implications of antiviral and immunosuppressive therapies. Arthritis Rheum 2002; 46(3): 585-97.
[http://dx.doi.org/10.1002/art.10107] [PMID: 11920393]
[45]
Cacoub P, Poynard T, Ghillani P, et al. MULTIVIRC Group. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42(10): 2204-12.
[http://dx.doi.org/10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D] [PMID: 10524695]
[46]
Donada C, Crucitti A, Donadon V, et al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. J Viral Hepat 1998; 5(3): 179-85.
[http://dx.doi.org/10.1046/j.1365-2893.1998.00097.x] [PMID: 9658371]
[47]
Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19(1): 111-29.
[http://dx.doi.org/10.1007/BF00945029] [PMID: 9266635]
[48]
Apartis E, Léger JM, Musset L, et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: A role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996; 60(6): 661-6.
[http://dx.doi.org/10.1136/jnnp.60.6.661] [PMID: 8648334]
[49]
David WS, Peine C, Schlesinger P, Smith SA. Nonsystemic vasculitic mononeuropathy multiplex, cryoglobulinemia, and hepatitis C. Muscle Nerve 1996; 19(12): 1596-602.
[http://dx.doi.org/10.1002/(SICI)1097-4598(199612)19:12<1596::AID-MUS9>3.0.CO;2-5] [PMID: 8941274]
[50]
Agnello V. Mixed cryoglobulinemia and other extrahepatic manifestations of hepatitis C virus infection. Hepatitis C San Diego Academic Press. 2000; pp. pp 295-313.
[http://dx.doi.org/10.1016/S1874-5326(00)80019-8]
[51]
Cacoub P, Maisonobe T, Thibault V, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001; 28(1): 109-18.
[PMID: 11196510]
[52]
Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40(11): 2007-15.
[http://dx.doi.org/10.1002/art.1780401113] [PMID: 9365090]
[53]
Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995; 47(2): 618-23.
[http://dx.doi.org/10.1038/ki.1995.78] [PMID: 7723249]
[54]
Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69(2): 287-308.
[http://dx.doi.org/10.1016/0002-9343(80)90390-3] [PMID: 6996482]
[55]
Frankel AH, Singer DR, Winearls CG, Evans DJ, Rees AJ, Pusey CD. Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients. Q J Med 1992; 82(298): 101-24.
[PMID: 1620812]
[56]
World Health Organisation. Global health observatory data Available at: http://www.who.int/gho/hiv/en/Accessed January, 2018.
[57]
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
[http://dx.doi.org/10.1056/NEJM199803263381301]
[58]
Murphy EL, Collier AC, Kalish LA, et al. Viral Activation Transfusion Study Investigators. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001; 135(1): 17-26.
[http://dx.doi.org/10.7326/0003-4819-135-1-200107030-00005] [PMID: 11434728]
[59]
Mocroft A, Reiss P, Gasiorowski J, et al. EuroSIDA Study Group. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010; 55(2): 262-70.
[http://dx.doi.org/10.1097/QAI.0b013e3181e9be6b] [PMID: 20700060]
[60]
Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214(2): 231-41.
[http://dx.doi.org/10.1002/path.2276] [PMID: 18161758]
[61]
Hunt PW. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 2012; 9(2): 139-47.
[http://dx.doi.org/10.1007/s11904-012-0118-8] [PMID: 22528766]
[62]
Weiss L, Haeffner-Cavaillon N, Laude M, Gilquin J, Kazatchkine MD. HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 α in vitro. AIDS 1989; 3(11): 695-9.
[http://dx.doi.org/10.1097/00002030-198911000-00002] [PMID: 2515876]
[63]
Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JE. Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest 1989; 84(3): 733-7.
[http://dx.doi.org/10.1172/JCI114230] [PMID: 2474573]
[64]
Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990; 86(1): 148-59.
[http://dx.doi.org/10.1172/JCI114678] [PMID: 2114424]
[65]
Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76(11): 2303-10.
[http://dx.doi.org/10.1182/blood.V76.11.2303.2303] [PMID: 2257304]
[66]
Lafeuillade A, Poizot-Martin I, Quilichini R, et al. Increased interleukin-6 production is associated with disease progression in HIV infection. AIDS 1991; 5(9): 1139-40.
[http://dx.doi.org/10.1097/00002030-199109000-00014] [PMID: 1930778]
[67]
Feffer SE, Fox RL, Orsen MM, Harjai KJ, Glatt AE. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J 1995; 88(11): 1126-30.
[http://dx.doi.org/10.1097/00007611-199511000-00008] [PMID: 7481983]
[68]
Bissuel F, Berruyer M, Causse X, Dechavanne M, Trepo C. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1988) 1992; 5(5): 484-9.
[PMID: 1532830]
[69]
Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 2006; 42(5): 572-7.
[http://dx.doi.org/10.1097/01.qai.0000230320.78288.79] [PMID: 16837864]
[70]
Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001; 15(6): 311-20.
[http://dx.doi.org/10.1089/108729101750279687] [PMID: 11445013]
[71]
Bibas M, Biava G, Antinori A. HIV-Associated Venous Thromboembolism. Mediterr J Hematol Infect Dis 2011; 3(1): e2011030.
[http://dx.doi.org/10.4084/mjhid.2011.030] [PMID: 21869916]
[72]
Saif MW, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS 2001; 15(1): 15-24.
[http://dx.doi.org/10.1089/108729101460065] [PMID: 11177584]
[73]
Eyal A, Veller M. HIV and venous thrombotic events. S Afr J Surg 2009; 47(2): 54-6.
[PMID: 19626781]
[74]
Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; 116(10): 1666-87.
[http://dx.doi.org/10.1093/cvr/cvaa106] [PMID: 32352535]
[75]
Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomarkers Med 2020; 14(9): 713-6.
[http://dx.doi.org/10.2217/bmm-2020-0201] [PMID: 32426991]
[76]
Hedrich CM, Schnabel A, Hospach T. Kawasaki Disease. Front Pediatr 2018; 6: 198.
[http://dx.doi.org/10.3389/fped.2018.00198]
[77]
Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395(10239): 1771-8.
[http://dx.doi.org/10.1016/S0140-6736(20)31103-X] [PMID: 32410760]
[78]
Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383(2): 120-8.
[http://dx.doi.org/10.1056/NEJMoa2015432] [PMID: 32437596]
[79]
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135(23): 2033-40.
[http://dx.doi.org/10.1182/blood.2020006000] [PMID: 32339221]
[80]
Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 2017; 7(9): e017046.
[http://dx.doi.org/10.1136/bmjopen-2017-017046] [PMID: 28963294]
[81]
Aggarwal S, Qamar A, Sharma V, Sharma A. Abdominal aortic aneurysm: A comprehensive review. Exp Clin Cardiol 2011; 16(1): 11-5.
[PMID: 21523201]
[82]
Nobile CJ, Johnson AD. Candida albicans Biofilms and Human Disease. Annu Rev Microbiol 2015; 69: 71-92.
[http://dx.doi.org/10.1146/annurev-micro-091014-104330] [PMID: 26488273]
[83]
Maguire EM, Pearce SWA, Xiao R, Oo AY, Xiao Q. Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection. Pharmaceuticals (Basel) 2019; 12(3): 118.
[http://dx.doi.org/10.3390/ph12030118] [PMID: 31390798]
[84]
Mettananda KC, De Silva ST, Premawardhena AP. Mycotic aneurysm of the descending aorta due to Aspergillus species. Ceylon Med J 2010; 55(1): 20-1.
[http://dx.doi.org/10.4038/cmj.v55i1.1705] [PMID: 20446537]
[85]
Sörelius K, di Summa PG. On the Diagnosis of Mycotic Aortic Aneurysms. Clin Med Insights Cardiol 2018; 12: 1179546818759678.
[http://dx.doi.org/10.1177/1179546818759678] [PMID: 29497343]
[86]
Tresson P, Roussel A, Mordant P, Cerceau P, Castier Y, Pellenc Q. Endovascular repair as a bridge to open repair of a ruptured descending thoracic Aspergillus aortitis. Ann Thorac Surg 2017; 104(6): e425-8.
[http://dx.doi.org/10.1016/j.athoracsur.2017.04.055] [PMID: 28499737]
[87]
Gjødsbøl K, Christensen JJ, Karlsmark T, Jørgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006; 3(3): 225-31.
[http://dx.doi.org/10.1111/j.1742-481X.2006.00159.x] [PMID: 16984578]
[88]
Fazli M, Bjarnsholt T, Kirketerp-Møller K, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 2009; 47(12): 4084-9.
[http://dx.doi.org/10.1128/JCM.01395-09] [PMID: 19812273]
[89]
Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology (Reading) 2009; 155(Pt 8): 2603-11.
[http://dx.doi.org/10.1099/mic.0.028712-0] [PMID: 19477903]
[90]
Maeda H, Akaike T, Sakata Y, Maruo K. Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin. Agents Actions Suppl 1993; 42: 159-65.
[http://dx.doi.org/10.1007/978-3-0348-7397-0_13] [PMID: 8356921]
[91]
Balakrishnan N, Ericson M, Maggi R, Breitschwerdt EB. Vasculitis, cerebral infarction and persistent Bartonella henselae infection in a child. Parasit Vectors 2016; 9(1): 254.
[http://dx.doi.org/10.1186/s13071-016-1547-9] [PMID: 27161220]
[92]
Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J Korean Med Sci 2020; 35(18): e174.
[http://dx.doi.org/10.3346/jkms.2020.35.e174] [PMID: 32383370]
[93]
Fong IW. Infections and their role in atherosclerotic vascular disease. J Am Dent Assoc 2002; 133(Suppl.): 7S-13S.
[http://dx.doi.org/10.14219/jada.archive.2002.0376] [PMID: 12085725]
[94]
Ielapi N, Nicoletti E, Lorè C, et al. The role of biofilm in central venous catheter related bloodstream infections: Evidence-based nursing and review of the literature. Rev Recent Clin Trials 2020; 15(1): 22-7.
[http://dx.doi.org/10.2174/1574887114666191018144739] [PMID: 31656155]
[95]
Vercellotti GM. Overview of infections and cardiovascular diseases. J Allergy Immunol 2001; S117-20.
[96]
de Franciscis S, Serra R. Matrix metalloproteinases and endothelial dysfunction: The search for new prognostic markers and for new therapeutic targets for vascular wall imbalance. Thromb Res 2015; 136(1): 5-6.
[http://dx.doi.org/10.1016/j.thromres.2015.04.022] [PMID: 25940670]
[97]
Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease--a possible trigger for acute myocardial infarction? Int J Epidemiol 1978; 7(3): 231-9.
[http://dx.doi.org/10.1093/ije/7.3.231] [PMID: 721358]
[98]
Provenzano M, Rotundo S, Chiodini P, et al. Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease. Int J Mol Sci 2020; 21(16): 5846.
[http://dx.doi.org/10.3390/ijms21165846] [PMID: 32823966]
[99]
Wilson WR, Bower TC, Creager MA, et al. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Peripheral Vascular Disease; and Stroke Council. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A scientific statement from the American heart association. Circulation 2016; 134(20): e412-60.
[http://dx.doi.org/10.1161/CIR.0000000000000457] [PMID: 27737955]
[100]
Miao CY, Li ZY. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 2012; 165(3): 643-58.
[http://dx.doi.org/10.1111/j.1476-5381.2011.01404.x] [PMID: 21470202]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 3
Year: 2021
Published on: 25 March, 2021
Page: [262 - 271]
Pages: 10
DOI: 10.2174/1574887116666210325124045
Price: $65

Article Metrics

PDF: 467
HTML: 1
EPUB: 1
PRC: 1